Skip to main content
. 2017 Jun 12;33(3):273–281. doi: 10.1007/s12291-017-0670-5

Table 3.

Prevalence of metabolic syndrome and DNA damage among groups

Treatment Prevalence of DNA damage (%) Prevalence of MS (%) P value
2nd line ART (n = 100) 83 71 <0.05
1st line ART (n = 100) 75 60 <0.05
ART naïve (n = 100) 38 27 <0.05
Control (n = 300) 7 17